Latest News

  • A COVID Diagnostics Reset: Making Accurate Diagnostics More Accessible

    Diagnostics World | At the height of the Omicron surge this winter, at-home rapid tests and PCR testing were hard to come by for everyone, but especially people with low-incomes, non-native English speakers, and immigrant communities. Along with more eligible people being vaccinated, an affordable, accessible NAAT test for the masses is the most effective way to live with the virus rather than being dominated by it again.

    Apr 22, 2022
  • Stanford: ‘Clinical Grade’ Long-Read Genome Sequencing Is Here

    Diagnostics World | A Stanford team led by Euan Ashley, professor of medicine, genetics and biomedical data science, sequenced a patient’s genome in a snappy five hours and two minutes on a PromethION platform from Oxford Nanopore, an achievement ratified by the Genome in a Bottle Consortium of the National Institute of Science and Technology.

    Apr 20, 2022
  • CLIA-Certified Alzheimer’s Blood Test Gets High Marks In Global Study

    Diagnostics World | A blood test to help clinicians diagnose Alzheimer’s disease is “on the road” to effectively replacing cerebrospinal fluid (CSF) testing and PET scans for detecting Alzheimer’s pathology, according to Randall J. Bateman, M.D., a professor of neurology at Washington University School of Medicine and co-developer of the plasma protein assay. A commercial version of the test, PrecivityAD, is already being used extensively in clinical trials as well to evaluate patients in real-world settings.

    Apr 19, 2022
  • Inactive Coagulation Proteins Could Be Key To Early Detection Of Sepsis

    Diagnostics World News | Coagulation factor proteins in the blood might be incorporated into standard blood tests to rapidly detect sepsis soon after infection but before disease symptoms such as excessive inflammation and blood clotting have happened, suggests a research initiative that markedly increased the survival of mice.

    Apr 14, 2022
  • EMA Endorses Biomarkers For Type 1 Diabetes Prevention Trials

    Diagnostics World | Following many years of collaborative patient-level data sharing across stakeholder groups, the European Medicines Agency (EMA) recently endorsed pancreatic islet autoantibodies as enrichment biomarkers for type 1 diabetes (T1D) trials focused on delaying or preventing the disease. The Qualification Opinion appears on both the EMA website and that of the Critical Path Institute’s (C-Path) Type 1 Diabetes Consortium (T1DC).

    Apr 11, 2022
  • The Relevance of Glycoproteomics to Diagnostics and Clinical Management

    Diagnostics World | For many clinicians, glycoproteomics is a new and unfamiliar field. However, this emerging “omic” has demonstrated potential to identify novel biomarkers and advance the field of diagnostics. Formerly confined to the research laboratory, the once daunting study of glycoproteomics (or “when sugar meet protein”) has been transformed by the use of machine learning.

    Apr 8, 2022